Services & Products
CRISPR-Cas9: Revolutionizing Gene Editing in Stem Cells
CRISPR-Cas9, discovered in 2012 by Jennifer Doudna and Emmanuelle Charpentier, is a revolutionary gene-editing tool that allows precise modification of DNA sequences in living organisms. This technology has enabled researchers to edit the genomes of iPSCs and other stem cells with unprecedented accuracy and efficiency.
…read more
By harnessing CRISPR-Cas9, scientists can introduce or correct genetic mutations in iPSCs [knock-out (KO), knock-in (KI) or point mutation], making them valuable tools for modeling genetic diseases, studying developmental processes, and potentially developing personalized therapies. The combination of iPSCs and CRISPR technology holds great promise for advancing regenerative medicine and understanding the molecular mechanisms underlying various diseases.
-
CRISPR/Cas9 Conditional Knockout iPSC Service
Cat.-Nr: ASC-6013-2
Cell lines with a loss-of-function gene mutation is an invaluable tool for studying and understanding function of genes and gene products. But a... Read More
-
CRISPR/Cas9 Knock-in iPSC Service
Cat.-Nr: ASC-6013-4
Applied StemCell is a leader in both CRISPR genome editing and iPSC technologies. We offer a combination CRISPR iPSC/ ES Cell Genome Editing Service... Read More
-
CRISPR/Cas9 Knockout iPSC Service
Cat.-Nr: ASC-6013-1
Applied StemCell is a leader in both CRISPR genome editing and iPSC technologies. We offer a combination CRISPR iPSC/ ES Cell Genome Editing Service... Read More
-
CRISPR/Cas9 Point Mutation iPSC Service
Cat.-Nr: ASC-6013-3
Point Mutation Cell Lines mimic mutations seen in clinical specimens and are important in vitro disease models to understand role of genes in... Read More